Acadia Healthcare Company, Inc.
NASDAQ•ACHC
CEO: Mr. Christopher Howal Hunter
セクター: Healthcare
業種: Medical - Care Facilities
上場日: 1994-03-04
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
連絡先情報
6100 Tower Circle, Suite 1000, Franklin, TN, 37067, United States
615-861-6000
時価総額
$2.19B
PER (TTM)
-1.9
50
配当利回り
--
52週高値
$31.04
52週安値
$11.43
52週レンジ
順位46Top 59.5%
3.5
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3.5 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q4 2025 データ
売上高
$821.46M+0.00%
直近4四半期の推移
EPS
-$13.02+0.00%
直近4四半期の推移
フリーCF
-$179.48M+0.00%
直近4四半期の推移
2025 Annual 決算ハイライト
主なハイライト
Revenue Growth Strong Revenue grew 5.0% to $3.31B USD in 2025; same facility revenue increased 4.9% driven by bed additions.
New Credit Facility Secured Secured $1.65B Credit Facility in February 2025, refinancing prior debt; Total Debt stands at $2.50B USD.
Facility Capacity Expansion Operated 277 behavioral facilities with 12,560 beds as of year-end 2025; added 1,089 beds during 2025.
Leverage Ratio Maintained Consolidated Total Net Leverage Ratio was 4.0x at year-end 2025, remaining in compliance with all financial covenants.
リスク要因
Major Goodwill Impairment Recorded $1.01B USD non-cash goodwill impairment charge in 2025 following triggering event analysis and lower projections.
High Labor Cost Pressure Salaries, wages, and benefits expense was $1.82B USD (55.0% of revenue); turnover increases labor costs impacting profitability.
Large Legal Settlement Costs Incurred $151.0M USD legal settlements expense in 2025, including $147.5M for 2019 Securities Litigation resolution.
Reimbursement Rate Volatility Revenue heavily reliant on Medicaid (57.7%); OBBBA legislation tightens eligibility and reduces federal expenditures.
見通し
Organic Growth Strategy Focus Strategy emphasizes facility expansions, joint ventures, and de novo builds to expand continuum of care access points.
Managing Capital Structure Actively managing capital structure; ability to fund growth depends on future financing availability on acceptable terms.
Cybersecurity Risk Mitigation Continually enhancing cybersecurity defenses against evolving threats; risks cannot be entirely eliminated per management.
Talent Acquisition Priority Success depends on attracting and retaining qualified psychiatrists, nurses, and support personnel despite intense market competition.
同業比較
売上高 (TTM)
$10.31B
$6.32B
$5.45B
粗利益率 (最新四半期)
165.5%
86.6%
71.1%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| BKD | $3.46B | -13.0 | -523.8% | 112.0% |
| HAE | $2.81B | 16.0 | 20.3% | 49.2% |
| LFST | $2.56B | 262.9 | 0.7% | 8.8% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
2.2%
緩やかな成長
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい
深度リサーチ
次回決算:2026年4月23日
EPS:$0.26
|売上高:$822.91M
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書 | 直近12ヶ月 |
|---|
データなし